HPV vaccination can prevent 70% of cervical cancers and 90% of genital warts. Pelin Batur, MD, discusses the latest vaccination timeline and dosing guidelines.
Expanding the Set of Cervical Cancer Prevention Tools Available for Underserved Populations
Despite advances in screening and treatment of cervical cancer, alternative low-cost methods are still needed to help underserved populations.
Cleveland Clinic Develops First Overall Risk Prediction Model for Cervical Cancer
In spite of advanced screening technology, thousands still die of cervical cancer each year. Learn how a new risk prediction model provides personalized screening and patient risk assessment.
Cervical Cancer in African American Women: Optimizing Prevention to Reduce Disparities
African American women are disproportionately affected by cervical cancer, with higher rates of incidence and mortality than white women. A clinician investigator shares her thoughts on how to end the disparity.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Striving to Eradicate Cervical Cancer in Underserved Countries
Nearly 90 percent of new cervical cancer cases are diagnosed in poor countries. Projects within the Cervical Cancer Prevention in El Salvador (CAPE) program target effective tools to increase patient access and acceptance of new screening and treatment methods.